CDKN2A and leukemia: Experimental results from Obexer et al. indicated that Bcl-2 protein and mRNA were markedly reduced after 48 h of p16INK4a expression in leukemia cells, suggesting that p16INK4a reconstitution at least in part exerts its effects via changes in the mRNA expression of Bcl-2 (43).